Rare Neurological Disease Treatment Market

Oral formulations represent 72.0% of the route of administration category and adult patients account for 58.0% of patient type demand in 2026. The rare neurological disease treatment market was valued at USD 20.0 billion in 2025 and is forecast to post a 7.4% CAGR between 2026 and 2036.